📰 Path Inc News
Page 19 - Path Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Path Inc. Real-time updates on events, politics, business and more.
May 9, 2022
After some respite in March, equities dropped again in April. The S&P 500 dropped 8.7%, while the NASDAQ lost over 13% last month. Also, only one
May 8, 2022
After some respite in March, equities dropped again in April. The S&P 500 dropped 8.7%, while the NASDAQ lost over 13% last month. Also, only one
May 6, 2022
We have referred to April return data to come up with the five worst and best performing large cap stocks in April 2022.
April 25, 2022
UiPath (NASDAQ:PATH – Get Rating) had its target price cut by stock analysts at KeyCorp from $34.00 to $23.00 in a report issued on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare company’s stock. KeyCorp’s price objective would indicate a potential upside of 28.13% from the company’s previous close. Several […]
April 18, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
April 15, 2022
Recognized Quote-to-Cash Thought Leader Reinforces Fast-Growing Company’s Opportunity to Capitalize on Broadening Market Demand and Accelerate Global Growth
April 11, 2022
We have used the Q1 return data to come up with the five best performing large-cap stocks in Q1 2022 and worst performing large-cap stocks in Q1 2022.
April 8, 2022
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
April 8, 2022
Zacks Investment Research cut shares of UiPath (NASDAQ:PATH – Get Rating) from a hold rating to a strong sell rating in a research note published on Thursday morning, Zacks.com reports. According to Zacks, “UiPath Inc. offers an end-to-end platform for automation, combining Robotic Process Automation solution for digital business operations. UiPath Inc. is based in […]
April 4, 2022
UiPath (NASDAQ:PATH – Get Rating) had its target price reduced by Truist Financial from $75.00 to $55.00 in a report released on Thursday morning, The Fly reports. Truist Financial currently has a buy rating on the healthcare company’s stock. A number of other research firms have also weighed in on PATH. Wells Fargo & Company […]